July 2002
917
d: 2.43 (ddd, 1H, Jϭ7.5, 9.3, 12.3 Hz), 3.15 (dt, 1H, Jϭ7.2, 12.3 Hz), 3.92
(3R*,5R*)-2-Benzyl-5-(1-hydroxybutyl)-3-phenylisoxazolidine (3
aI-2):
(d, 1H, Jϭ14.1 Hz), 4.09 (dd, 1H, Jϭ7.2, 9.3 Hz), 4.11 (d, 1H, Jϭ14.1 Hz), Diastereomer B: 1H-NMR (CDCl3) d: 0.92 (t, 3H, Jϭ7.2 Hz), 1.20—1.60
5.27 (t, 1H, Jϭ7.5 Hz), 7.22—7.54 (m, 15H). HR-MS m/z; 315.1629 (Calcd
(m, 4H), 2.50—2.68 (m, 2H), 3.56 (s, 1H), 3.63 (d, 1H, Jϭ14.4 Hz), 3.79
(dd, 1H, Jϭ8.1, 9.0 Hz), 3.95—4.04 (m, 2H), 3.99 (d, 1H, Jϭ14.4 Hz), 4.16
(ddd, 1H, Jϭ2.4, 6.0, 8.4 Hz), 7.21—7.50 (m, 10H). HR-MS m/z; 311.1889
for C22H21NO: 315.1623).
(3R*,5R*)-2-Benzyl-3,5-diphenylisoxazolidine (3
aC): H-NMR (CDCl3)
1
d: 2.60 (ddd, 1H, Jϭ6.3, 8.4, 12.6 Hz), 2.75 (dt, 1H, Jϭ8.4, 12.6 Hz), (Calcd for C20H25NO2: 311.1885).
3.97—4.15 (m, 1H), 5.23—5.30 (m, 1H), 7.22—7.54 (m, 15H). HR-MS
(3R*,5S*)-2-Benzyl-5-(1-methyl-1-hydroxyethyl)-3-phenylisoxazolidine
m/z; 315.1626 (Calcd for C22H21NO: 315.1623).
(3aJ): 1H-NMR (CDCl3) d: 1.13 (s, 3H), 1.28 (s, 3H), 1.82—1.95 (br s, 1H),
(3R*,5S*)-2-Benzyl-5-butoxy-3-phenylisoxazolidine (3aD): 1H-NMR 2.23 (dt, 1H, Jϭ8.4, 11.4 Hz), 2.56—2.65 (m, 1H), 3.73 (d, 1H, Jϭ14.1 Hz),
(CDCl3) d: 0.91 (t, 3H, Jϭ7.2 Hz), 1.33—1.45 (m, 2H), 1.53—1.63 (m,
2H), 2.31 (ddd, 1H, Jϭ3.0, 9.3, 12.9 Hz), 2.89 (ddd, 1H, Jϭ6.3, 8.1,
3.70—3.80 (m, 1H), 4.03 (d, 1H, Jϭ14.1 Hz), 4.03 (dd, 1H, Jϭ8.4,
11.4 Hz), 7.21—7.50 (m, 10H). HR-MS m/z; 297.1731 (Calcd for
12.9 Hz), 3.40 (dt, 1H, Jϭ6.6, 9.6 Hz), 3.68 (d, 1H, Jϭ14.7 Hz), 3.70 (dd, C19H23NO2: 297.1729).
1H, Jϭ8.1, 9.3 Hz), 3.71 (dt, 1H, Jϭ6.6, 9.6 Hz), 4.03 (d, 1H, Jϭ14.7 Hz),
(3R*,5R*)-2-Benzyl-5-(1-methyl-1-hydroxyethyl)-3-phenylisoxazolidine
5.16 (dd, 1H, Jϭ3.0, 6.3 Hz), 7.21—7.56 (m, 10H). HR-MS m/z; 311.1880 (3
aJ): 1H-NMR (CDCl3) d: 1.10 (s, 3H), 1.19 (s, 3H), 2.56 (ddd, 1H,
(Calcd for C20H25NO2: 311.1885).
Jϭ6.0, 9.9, 12.3 Hz), 2.67 (dt, 1H, Jϭ7.8, 12.3 Hz), 3.37 (s, 1H), 3.62 (d,
(3R*,5R*)-2-Benzyl-5-butoxy-3-phenylisoxazolidine (3
aD): 1H-NMR 1H, Jϭ14.1 Hz), 3.79 (dd, 1H, Jϭ7.8, 9.9 Hz), 3.95 (d, 1H, Jϭ14.1 Hz),
(CDCl3) d: 0.97 (t, 3H, Jϭ7.2 Hz), 1.40—1.48 (m, 2H), 1.58—1.67 (m, 3.93—3.98 (m, 1H), 7.24—7.48 (m, 10H). HR-MS m/z; 297.1733 (Calcd for
2H), 2.46 (ddd, 1H, Jϭ4.8, 10.2, 12.6 Hz), 2.64 (ddd, 1H, Jϭ0.9, 6.6, C19H23NO2: 297.1729).
12.6 Hz), 3.43 (dt, 1H, Jϭ6.9, 9.3 Hz), 3.82 (dt, 1H, Jϭ6.9, 9.3 Hz), 4.09 (s,
(3R*,5S*)-5-(Allyloxymethyl)-2-benzyl-3-phenylisoxazolidine (3aK):
2H), 4.32 (dd, 1H, Jϭ 6.6, 10.2 Hz), 5.19 (d, 1H, Jϭ4.8 Hz), 7.21—7.45 (m, 1H-NMR (CDCl3) d: 2.04 (ddd, 1H, Jϭ6.3, 9.0, 12.6 Hz), 2.78 (dt, 1H,
10H). HR-MS m/z; 311.1884 (Calcd for C20H25NO2: 311.1885).
Jϭ7.8, 12.6 Hz), 3.47 (dd, 1H, Jϭ4.5, 10.2 Hz), 3.71 (t, 1H, Jϭ6.9 Hz), 3.77
(3R*,5S*)-5-Acetoxy-2-benzyl-3-phenylisoxazolidine (3aE): 1H-NMR (d, 1H, Jϭ14.7 Hz), 3.92—4.07 (m, 3H), 3.98 (d, 1H, Jϭ14.7 Hz), 4.35—
(CDCl3) d: 2.11 (s, 3H), 2.41 (ddd, 1H, Jϭ3.0, 9.3, 13.8 Hz), 3.04 (ddd, 1H, 4.44 (m, 1H), 5.11—5.33 (m, 2H), 5.79—5.98 (m, 1H), 7.20—7.50 (m,
Jϭ6.6, 8.1, 13.8 Hz), 3.80 (d, 1H, Jϭ14.7 Hz), 3.80 (dd, 1H, Jϭ8.1, 9.3 Hz),
4.08 (d, 1H, Jϭ14.7 Hz), 6.36 (dd, 1H, Jϭ3.0, 6.6 Hz), 7.22—7.57 (m,
10H). HR-MS m/z; 297.1364 (Calcd for C18H19NO3: 297.1365).
10H). HR-MS m/z; 309.1725 (Calcd for C20H23NO2: 309.1729).
(3R*,5R*)-5-(Allyloxymethyl)-2-benzyl-3-phenylisoxazolidine (3
aK):
1H-NMR (CDCl3) d: 2.38 (dt, 1H, Jϭ7.8, 12.3 Hz), 2.51 (ddd, 1H, Jϭ5.4,
(3R*,5R*)-5-Acetoxy-2-benzyl-3-phenylisoxazolidine (3
aE): 1H-NMR 7.8, 12.3 Hz), 3.54 (d, 1H, Jϭ4.5 Hz), 3.77 (d, 1H, Jϭ14.7 Hz), 3.83 (d, 1H,
(CDCl3) d: 2.08 (s, 3H), 2.63 (dd, 2H, Jϭ3.0, 8.4 Hz), 4.02 (d, 1H,
Jϭ13.8 Hz), 4.15 (d, 1H, Jϭ13.8 Hz), 4.25 (t, 1H, Jϭ8.4 Hz), 6.39 (t, 1H,
Jϭ8.1 Hz), 3.92—4.07 (m, 3H), 3.98 (d, 1H, Jϭ14.7 Hz), 4.35—4.44 (m,
1H), 5.11—5.33 (m, 2H), 5.79—5.98 (m, 1H), 7.20—7.50 (m, 10H). HR-
Jϭ3.0 Hz), 7.24—7.51 (m, 10H). HR-MS m/z; 297.1372 (Calcd for MS m/z; 309.1729 (Calcd for C20H23NO2: 309.1729).
C18H19NO3: 297.1365).
(3R*,5S*)-2-Benzyl-5-(methylthio)-3-phenylisoxazolidine (3aL): 1H-
(3R*,5S*)-2-Benzyl-5-(bromomethyl)-3-phenylisoxazolidine (3aF): mp. NMR (CDCl3) d: 2.03 (s, 3H), 2.16 (ddd, 1H, Jϭ6.0, 9.0, 12.6 Hz), 2.66 (dd,
1
74—76 °C; H-NMR (CDCl3) d: 2.23 (ddd, 1H, Jϭ5.4, 9.0, 12.6 Hz), 2.92
(dt, 1H, Jϭ7.5, 12.6 Hz), 3.46 (dd, 1H, Jϭ8.1, 9.6 Hz), 3.66 (dd, 1H, Jϭ5.7,
9.6 Hz), 3.75 (d, 1H, Jϭ14.7 Hz), 3.86 (dd, 1H, Jϭ7.5, 9.0 Hz), 4.00 (d, 1H,
Jϭ14.7 Hz), 4.39—4.48 (m, 1H), 7.23—7.44 (m, 10H).
1H, Jϭ6.6, 13.5 Hz), 2.88 (dt, 1H, Jϭ7.5, 12.6 Hz), 2.90 (dd, 1H, Jϭ6.6,
13.5 Hz), 3.74 (d, 1H, Jϭ14.4 Hz), 3.86 (dt, 1H, Jϭ6.6, 13.5 Hz), 3.98 (d,
1H, Jϭ14.1 Hz), 4.13 (dt, 1H, Jϭ5.4, 8.1 Hz), 7.21—7.45 (m, 10H). HR-
MS m/z; 299.1338 (Calcd for C18H21NOS: 299.1344).
(3R*,5R*)-2-Benzyl-5-(bromomethyl)-3-phenylisoxazolidine (3
aF): Col-
(3R*,5R*)-2-Benzyl-5-(methylthio)-3-phenylisoxazolidine (3
aL): 1H-
orless oil; 1H-NMR (CDCl3) d: 2.51 (dt, 1H, Jϭ8.7, 12.6 Hz), 2.57 (ddd, NMR (CDCl3) d: 2.18 (s, 3H), 2.45—2.50 (m, 2H), 2.67 (dd, 1H, Jϭ6.9,
1H, Jϭ5.1, 7.5, 12.6 Hz), 3.42 (dd, 1H, Jϭ6.6, 10.2 Hz), 3.50 (dd, 1H, 13.8 Hz), 2.75 (dd, 1H, Jϭ4.8, 14.4 Hz), 3.75 (d, 1H, Jϭ14.1 Hz), 3.98 (dd,
Jϭ7.2, 10.2 Hz), 3.76 (d, 1H, Jϭ14.4 Hz), 3.88 (dd, 1H, Jϭ7.5, 8.7 Hz), 1H, Jϭ14.1 Hz), 4.35—4.49 (m, 2H), 7.20—7.50 (m, 10H). HR-MS m/z;
3.98 (d, 1H, Jϭ14.4 Hz), 4.42—4.50 (m, 1H), 7.24—7.47 (m, 10H).
(3R*,5S*)-2-Benzyl-5-(hydroxymethyl)-3-phenylisoxazolidine (3aG): 1H-
NMR (CDCl3) d: 1.63 (br s, 1H), 2.25 (ddd, 1H, Jϭ5.4, 9.3, 12.3 Hz), 2.79
(dt, 1H, Jϭ8.1, 12.3 Hz), 3.66 (d, 1H, Jϭ14.4 Hz), 3.74—3.83 (m, 3H), 3.99
299.1343 (Calcd for C18H21NOS: 299.1344).
(3R*,5R*)-2-Benzyl-5-(methylthio)-3-phenylisoxazolidine (3aM): 1H-
NMR (CDCl3) d: 0.88 (t, 3H, Jϭ6.9 Hz), 1.23—1.40 (m, 8H), 1.45—1.60
(m, 1H), 1.73—1.86 (m, 1H), 1.99 (ddd, 1H, Jϭ7.2, 8.7, 12.0 Hz), 2.78 (dt,
(d, 1H, Jϭ14.4 Hz), 4.30—4.39 (m, 1H), 7.24—7.48 (m, 10H). HR-MS m/z; 1H, Jϭ7.2, 12.0 Hz), 3.84 (d, 1H, Jϭ14.1 Hz), 3.94 (d, 1H, Jϭ11.7 Hz),
269.1621 (Calcd for C17H19NO2: 269.1416).
3.99 (d, 1H, Jϭ14.1 Hz), 4.16—4.26 (m, 1H), 7.20—7.50 (m, 10H). HR-MS
m/z; 323.2244 (Calcd for C22H29NO: 323.2249).
(3R*,5R*)-2-Benzyl-5-(hydroxymethyl)-3-phenylisoxazolidine (3
aG):
1H-NMR (CDCl3) d: 1.83 (brs, 1H), 2.37 (dt, 1H, Jϭ8.7, 12.3 Hz), 2.55
(ddd, 1H, Jϭ5.4, 7.8, 12.3 Hz), 3.56—3.82 (m, 3H), 3.70 (d, 1H,
Jϭ14.4 Hz), 3.98 (d, 1H, Jϭ14.4 Hz), 4.03—4.39 (m, 1H), 7.24—7.48 (m,
10H). HR-MS m/z; 269.1622 (Calcd for C17H19NO2: 269.1416).
(3R*,5S*)-5-(Acetoxymethyl)-2-benzyl-3-phenylisoxazolidine (3aH): H- 3.99 (d, 1H, Jϭ14.1 Hz), 4.16—4.26 (m, 1H), 7.20—7.50 (m, 10H). HR-MS
(3R*,5S*)-2-Benzyl-5-(methylthio)-3-phenylisoxazolidine (3
aM): 1H-
NMR (CDCl3) d: 0.88 (t, 3H, Jϭ6.9 Hz), 1.23—1.40 (m, 8H), 1.45—1.60
(m, 1H), 1.73—1.86 (m, 1H), 2.18 (ddd, 1H, Jϭ6.3, 8.4, 12.0 Hz), 2.36 (dt,
1 H, Jϭ8.1, 12.3 Hz), 3.74 (d, 1H, Jϭ14.1 Hz), 3.88 (d, 1H, Jϭ11.1 Hz),
1
NMR (CDCl3) d: 2.00—2.10 (m, 1H), 2.02 (s, 3H), 2.83 (dt, 1H, Jϭ8.1,
12.9 Hz), 3.77 (d, 1H, Jϭ14.7 Hz), 3.83 (t, 1H, Jϭ8.1 Hz), 4.00 (d, 1H,
Jϭ14.7 Hz), 4.11 (d, 1H, Jϭ11.4 Hz), 4.53 (d, 1H, Jϭ11.1 Hz), 4.38—4.47 (3aN): H-NMR (CDCl3) d: 1.33 (t, 3H, Jϭ7.2 Hz), 1.59 (s, 3H), 2.32 (dd,
(m, 1H), 7.17—7.45 (m, 10H). HR-MS m/z; 311.1518 (Calcd for 1H, Jϭ9,6, 12.6 Hz), 3.10 (dd, 1H, Jϭ6.9, 12.6 Hz), 3.97 (s, 2H), 4.06 (dd,
m/z; 323.2239 (Calcd for C22H29NO: 323.2249).
Ethyl (3R*,5R*)-2-Benzyl-5-methy-3-phenylisoxazolidin-5-carboxylate
1
C19H21NO3: 311.1521).
1H, Jϭ6.9, 9.6 Hz), 4.25 (q, 2H, Jϭ7.2 Hz), 7.20—7.45 (m, 10H). HR-MS
(3R*,5R*)-5-(Acetoxymethyl)-2-benzyl-3-phenylisoxazolidine (3
aH): m/z; 325.1678 (Calcd for C20H23NO3: 325.1678).
1H-NMR (CDCl3) d: 2.08 (s, 3H), 2.41 (t, 2H, Jϭ8.1 Hz), 3.74 (d, 1H,
Ethyl (3R*,5S*)-2-Benzyl-5-methy-3-phenylisoxazolidin-5-carboxylate
Jϭ14.4 Hz), 3.83 (t, 1H, Jϭ8.1 Hz), 4.00 (d, 1H, Jϭ14.7 Hz), 4.12 (d, 1H, (3
aN): 1H-NMR (CDCl3) d: 1.31 (t, 3H, Jϭ7.2 Hz), 1.54 (s, 3H), 2.49 (dd,
Jϭ11.1 Hz), 4.35 (d, 1H, Jϭ11.1 Hz), 4.38—4.47 (m, 1H), 7.17—7.45 (m,
1H, Jϭ8.4, 12.6 Hz), 3.03 (dd, 1H, Jϭ8.4, 12.6 Hz), 3.76 (d, 1H,
Jϭ15.3 Hz), 3.81 (t, 1H, Jϭ8.4 Hz), 3.99 (d, 1H, Jϭ15.3 Hz), 4.24 (q, 2H,
10H). HR-MS m/z; 311.1514 (Calcd for C19H21NO3: 311.1521).
(3R*,5S*)-2-Benzyl-5-(1-hydroxybutyl)-3-phenylisoxazolidine (3aI): H- Jϭ7.2 Hz), 7.20—7.45 (m, 10H). HR-MS m/z; 325.1684 (Calcd for
1
NMR (CDCl3) d: 0.92 (t, 3H, Jϭ7.2 Hz), 1.31—1.55 (m, 4H), 2.23 (ddd,
1H, Jϭ5.4, 9.3, 12.6 Hz), 2.79 (dt, 1H, Jϭ8.1, 12.6 Hz), 3.05 (d, 1H,
C20H23NO3: 325.1678).
(3R*,5R*)-2-Benzyl-5-cyano-5-methyl-3-phenylisoxazolidine (3aP): 1H-
Jϭ4.5 Hz), 3.65 (d, 1H, Jϭ14.4 Hz), 3.65—3.72 (m, 1H), 3.79 (dt, 1H, NMR (CDCl3) d: 1.70 (s, 3H), 2.50 (dd, 1H, Jϭ9.0, 12.6 Hz), 3.13 (dd, 1H,
Jϭ8.1, 9.3 Hz), 3.97 (d, 1H, Jϭ14.4 Hz), 3.97—4.03 (m, 1H), 7.21—7.50
(m, 10H). HR-MS m/z; 311.1880 (Calcd for C20H25NO2: 311.1885).
(3R*,5R*)-2-Benzyl-5-(1-hydroxybutyl)-3-phenylisoxazolidine (3
aI-1):
Diastereomer A: 1H-NMR (CDCl3) d: 0.92 (t, 3H, Jϭ7.2 Hz), 1.34—1.56
Jϭ6.3, 12.6 Hz), 4.06 (d, 1H, Jϭ13.8 Hz), 4.14 (d, 1H, Jϭ13.9 Hz), 4.42
(dd, 1H, Jϭ6.3, 9.3 Hz), 7.26—7.44 (m, 10H). HR-MS m/z; 278.1417
(Calcd for C18H18N2O: 278.1419).
(3R*,5S*)-2-Benzyl-5-cyano-5-methyl-3-phenylisoxazolidine (3ЈaP): 1H-
(m, 4H), 1.90—2.05 (br s, 1H), 2.36 (dt, 1H, Jϭ8.1, 12.3 Hz), 2.45 (m, 1H), NMR (CDCl3) d: 1.69 (s, 3H), 2.67 (dd, 1H, Jϭ9.0, 12.9 Hz), 2.83 (dd, 1H,
3.48—3.54 (m, 1H), 3.73 (d, 1H, Jϭ14.1 Hz), 3.76—3.85 (m, 1H), 3.98 (d, Jϭ8.4, 12.9 Hz), 3.77 (d, 1H, Jϭ15.3 Hz), 3.83 (t, 1H, Jϭ8.7 Hz), 4.06 (d,
1H, Jϭ14.1 Hz), 4.13 (dt, 1H, Jϭ5.4, 8.1 Hz), 7.21—7.50 (m, 10H). HR- 1H, Jϭ15.3 Hz), 7.25—7.56 (m, 10H). HR-MS m/z; 278.1422 (Calcd for
MS m/z; 311.1888 (Calcd for C20H25NO2: 311.1885).
C18H18N2O: 278.1419).